All lanes : Anti-Breast cancer suppressor candidate 1 antibody [3D6] (ab123932) at 1/2000 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control Lane 2 : HEK293T cells transfected with pCMV6-ENTRY Breast cancer suppressor candidate 1Lysates/proteins at 5 µg per lane.
ab123932 at 1/150 dilution staining Breast cancer suppressor candidate 1 in formalin-fixed, Paraffin-embedded tissue adenocarcinoma of human breast tissue by Immunohistochemistry.
ab123932 at 1/150 dilution staining Breast cancer suppressor candidate 1 in Formalin-fixed, Paraffin-embedded tissue carcinoma of Human lung tissue by immunohistochemistry.
ab123932 at 1/150 dilution staining Breast cancer suppressor candidate 1 in Formalin-fixed, Paraffin-embedded tissue human pancreas tissue by Immunohistochemistry.
ab123932 at 1/150 dilution staining Breast cancer suppressor candidate 1 in Formalin-fixed, Paraffin-embedded tissue human lymph node tissue by Immunohistochemistry.
ab123932 at 1/150 dilution staining Breast cancer suppressor candidate 1 in Human lymphoma tissue by Immunohistochemistry Formalin-fixed, Paraffin-embedded tissue.
ab123932, at 1/100, immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY Breast cancer suppressor candidate 1.
Flow cytometric Analysis of Hela cells, using ab123932 at 1/100 dilution,(Red), compared to a nonspecific negative control antibody,(Blue).
Flow cytometric Analysis of Jurkat cells, using ab123932 at 1/100 dilution,(Red), compared to a nonspecific negative control antibody,(Blue).